TNFRSF11A Protein (Fc Tag)

Catalog No. ABIN7198423

This Recombinant TNFRSF11A protein is expressed in HEK-293 Cells.

Quick Overview for TNFRSF11A Protein (Fc Tag) (ABIN7198423)

Target: TNFRSF11A (Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A))

Protein Type: Recombinant

Origin: Rat

Source: HEK-293 Cells

Purity: > 80 % as determined by SDS-PAGE

Product Details

Purification tag / Conjugate: This TNFRSF11A protein is labelled with Fc Tag.

Purpose: Recombinant Rat RANK/TNFRSF11A Protein (Fc Tag)

Sequence: Met1-Pro213

Characteristics: A DNA sequence encoding the rat TNFRSF11A (Met1-Pro213) was expressed, fused with the Fc region of human IgG1 at the C-terminus.

Endotoxin Level: < 1.0 EU per μg of the protein as determined by the LAL method

Application Details

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please refer to the printed manual for detailed information.

Buffer: Lyophilized from sterile PBS, pH 7.4

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Target Details

Target: TNFRSF11A (Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A))

Alternative Name: RANK/TNFRSF11A

Background:

Background: TNFRSF11A is a member of the TNF-receptor superfamily. In mouse, it is also known as CD265. TNFRSF11A contains 4 TNFR-Cys repeats and is widely expressed with high levels in skeletal muscle, thymus, liver, colon, small intestine and adrenal gland. It is an essential mediator for osteoclast and lymph node development. TNFRSF11A and its ligand are important regulators of the interaction between T cells and dendritic cells. It can interact with various TRAF family proteins, through which this receptor induces the activation of NF-kappa B and MAPK8/JNK. Defects in TNFRSF11A can cause familial expansile osteolysis (FEO). FEO is a rare autosomal dominant bone disorder characterized by focal areas of increased bone remodeling. Defects in TNFRSF11A also can cause Paget disease of bone type 2 (PDB2). PDB2 is a bone-remodeling disorder with clinical similarities to FEO. Defects in TNFRSF11A are the cause of osteopetrosis autosomal recessive type 7 which characterized by abnormally dense bone, due to defective resorption of immature bone.

Synonym: RGD1563614

Molecular Weight: 47.1 kDa

NCBI Accession: NP_001258164

Pathways: NF-kappaB Signaling